3-溴-4-(甲硫基)苯甲醛 | 694481-10-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴-4-(甲硫基)苯甲醛
• 英文名称: 3-bromo-4-(methylthio)benzaldehyde
• 英文别名: 3-bromo-4-methylsulfanylbenzaldehyde
• CAS: 694481-10-2
• 化学式: C₈H₇BrOS
• 分子量: 231.113
• InChiKey: ZFWZQTCSPIPGKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  42.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-溴-4-(甲硫基)苯甲醛 在 吡啶 、 盐酸 、 水 、 sodium acetate 、 乙酸酐 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 1,4-二氧六环 为溶剂， 生成
  参考文献：
  名称：

  Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets

  摘要：

  Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC50 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotcodcity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.

  DOI：

  10.1021/jm2016182
• 作为产物：
  描述：

  3-溴-4-氟苯甲醛 、 sodium thiomethoxide 在 potassium carbonate 作用下， 以 N-甲基吡咯烷酮 为溶剂， 反应 7.0h， 以44%的产率得到3-溴-4-(甲硫基)苯甲醛
  参考文献：
  名称：

  [EN] 2-PYRIDONE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE
  [FR] DERIVES DE 2-PYRIDONE EN TANT QU'INHIBITEURS DE L'ELASTASE DE NEUTROPHILE

  摘要：

  提供了化学式（I）中的新化合物，其中R1、R4、R5、G1、G2、X、L、Y1、Y2和n的定义如专利说明书中所述，以及其光学异构体、消旋体和互变异构体，以及其药学上可接受的盐；以及它们的制备方法，含有它们的组合物以及它们在治疗中的用途。这些化合物是中性粒细胞弹性蛋白酶的抑制剂。

  公开号：

  WO2004043924A1

文献信息

• Palladium-Assisted “Aromatic Metamorphosis” of Dibenzothiophenes into Triphenylenes
  作者：Dhananjayan Vasu、Hideki Yorimitsu、Atsuhiro Osuka

  DOI：10.1002/anie.201501992

  日期：2015.6.8

  Two new palladium‐catalyzed reactions of aromatic sulfur compounds enabled the conversion of dibenzothiophenes into triphenylenes in four steps. This transformation of one aromatic framework into another consists of 1) 4‐chlorobutylation of the dibenzothiophene to form the corresponding sulfonium salt, 2) palladium‐catalyzed arylative ring opening of the sulfonium salt with a sodium tetraarylborate

  芳香族硫化合物的两个新的钯催化反应使二苯并噻吩在四个步骤中转化为苯并菲。一种芳族骨架向另一种芳族骨架的转化包括：1）二苯并噻吩的4-氯丁基化反应形成相应的sulf盐； 2）钯盐与四芳基硼酸钠的钯催化的芳基开环反应； 3）分子内S N 2反应以形成teraryl锍盐，和4）的钯催化的分子内ç  S / C  H至电palladation耦合。以量身定制的方式合成了所需的对称和不对称的三亚苯基，其总收率令人满意。
• Development of a Robust and Practical Process for the Darzens Condensation and α,β-Epoxide Rearrangement: Scope and Limitations of the Methodology
  作者：Fabrice Gallou、Jeremy Zimbron、Manuela Seeger-Weibel、Hans Hirt

  DOI：10.1055/s-2008-1067002

  日期：2008.4

  benzaldehydes and subsequent α,β-epoxy rearrangement is reported. The process developed is both amenable to large scale and parallel synthesis. While electron-poor benzaldehydes gave mixtures of aryl ketones and 2-substituted aryl ketones in mediocre to low yields, electron-rich benzaldehydes were found to react in high yields with complete regioselectivity to form 2-substituted aryl ketones.

  报道了取代苯甲醛的 Darzens 缩合和随后的 α,β-环氧重排的实用且稳健的过程。所开发的工艺既适用于大规模合成，也适用于平行合成。虽然贫电子苯甲醛以中等至低产率产生芳基酮和 2-取代芳基酮的混合物，但发现富电子苯甲醛以高产率反应形成 2-取代芳基酮，具有完全的区域选择性。
• 2-Pyridone derivatives as inhibitors of neutrophile elastase
  申请人：Bladh Hakan

  公开号：US20060035938A1

  公开（公告）日：2006-02-16

  There are provided novel compounds of formula (I) wherein R 1?, R 4?. R 5?, G 1?, G 2?, X, L, Y 1?, Y 2? and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors or neutrophil elastase.

  提供了式(I)的新化合物，其中R1？，R4？，R5？，G1？，G2？，X，L，Y1？，Y2？和n如规范中所定义，以及其光学异构体，外消旋体和互变异构体，以及药学上可接受的盐；以及它们的制备过程，含有它们的组合物和它们在治疗中的应用。这些化合物是中性粒细胞弹性蛋白酶的抑制剂。
• Substituted arylalkanoic acid derivatives and use thereof
  申请人：Shoda Motoshi

  公开号：US20070213333A1

  公开（公告）日：2007-09-13

  A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C 2 to C 6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

  化合物的化学式为（I）：[在公式中，Link代表饱和或不饱和的直链碳氢链，其具有1至3个碳原子，C2至C6在芳环（E）中独立地表示构成环的碳原子，构成环的碳原子中的一个可以被V取代，V代表氮原子，或被Zx取代的碳原子，Zx代表饱和的烷基基团，其具有1至4个碳原子等，Rs代表-D-Rx等，D代表单键，氧原子等，Rx代表饱和的烷基基团，其具有3至8个碳原子等，AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环，Y代表氢原子，具有1至4个碳原子的低烷基基团等]或其盐。提供了一种具有前列腺素生成抑制作用和白三烯生成抑制作用的化合物。
• 2-PYRIDONE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE
  申请人：AstraZeneca AB

  公开号：EP1562902B1

  公开（公告）日：2006-05-03